Literature DB >> 12365001

Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy.

R F Duarte1, F E Chen, M W Lowdell, M N Potter, M L Lamana, H G Prentice, J A Madrigal.   

Abstract

The immune function of retrovirus-mediated gene modified (GM) T cells is critical for a beneficial effect to follow their adoptive transfer into patients. Recent clinical data show that GM T cells expanded with PHA have reduced function in vivo. However, little functional analysis of PHA stimulation is available. Our results show that expansion of T cells with PHA impairs their ability to respond (proliferation, cytotoxicity and IFN gamma and perforin expression) to allogeneic stimulation or viral antigens in vitro. Conversely, CD3/CD28-based protocols can preserve this immune function. Retroviral transduction did not alter the functional profile induced by polyclonal stimulation. We investigated the mechanisms leading to this functional effect, and identified differential effects of PHA and CD3/CD28 on the distribution of CCR7/CD45RA T cell functional subsets, which may explain the functional differences observed. While CD3/CD28 stimulation parallels the lineage differentiation pattern induced by antigens in physiological conditions, PHA induces a skewed distribution of the CCR7/CD45RA functional T cell subsets, with near disappearance of the subpopulations that display the effector phenotype. Overall, this study demonstrates a functional disadvantage for transduction protocols based on PHA, uncovers mechanisms that may explain this functional effect, and provides us with information to design and select transduction protocols with an improved functional outcome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12365001     DOI: 10.1038/sj.gt.3301807

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  14 in total

Review 1.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

2.  Longitudinal relationships between rheumatoid factor and cytokine expression by immunostimulated peripheral blood lymphocytes from patients with rheumatoid arthritis: New insights into B-cell activation.

Authors:  John M Davis; Cynthia S Crowson; Keith L Knutson; Sara J Achenbach; Michael A Strausbauch; Terry M Therneau; Eric L Matteson; Sherine E Gabriel; Peter J Wettstein
Journal:  Clin Immunol       Date:  2020-01-08       Impact factor: 3.969

3.  T cell receptor-engineered T cells to treat solid tumors: T cell processing toward optimal T cell fitness.

Authors:  Cor H J Lamers; Sabine van Steenbergen-Langeveld; Mandy van Brakel; Corrien M Groot-van Ruijven; Pascal M M L van Elzakker; Brigitte van Krimpen; Stefan Sleijfer; Reno Debets
Journal:  Hum Gene Ther Methods       Date:  2014-12       Impact factor: 2.396

4.  Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes.

Authors:  Steven M Kornblau; Preston G Aycox; Clifton Stephens; L David McCue; Richard E Champlin; Frank C Marini
Journal:  Exp Hematol       Date:  2007-05       Impact factor: 3.084

5.  In vitro co-stimulation with anti-CD28 synergizes with IL-12 in the generation of T cell immune responses to leukaemic cells; a strategy for ex-vivo generation of CTL for immunotherapy.

Authors:  J K Orleans-Lindsay; A Deru; J I O Craig; H G Prentice; M W Lowdell
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

6.  Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells.

Authors:  Nicolas Montcuquet; Patricia Mercier-Letondal; Sylvain Perruche; Anne Duperrier; Mélanie Couturier; Abdelghani Bouchekioua; Mark Bonyhadi; Christophe Ferrand; Pierre Tiberghien; Eric Robinet
Journal:  Immunology       Date:  2008-04-26       Impact factor: 7.397

7.  α4β7+ CD4+ Effector/Effector Memory T Cells Differentiate into Productively and Latently Infected Central Memory T Cells by Transforming Growth Factor β1 during HIV-1 Infection.

Authors:  Ka-Wai Cheung; Tongjin Wu; Sai Fan Ho; Yik Chun Wong; Li Liu; Hui Wang; Zhiwei Chen
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

8.  Comparison of anti-CD3 and anti-CD28-coated beads with soluble anti-CD3 for expanding human T cells: differing impact on CD8 T cell phenotype and responsiveness to restimulation.

Authors:  Yixin Li; Roger J Kurlander
Journal:  J Transl Med       Date:  2010-10-26       Impact factor: 5.531

9.  Nivolumab Enhances In Vitro Effector Functions of PD-1+ T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner.

Authors:  Christodoulos Filippis; Katharina Arens; Gaetan Aime Noubissi Nzeteu; Gabriele Reichmann; Zoe Waibler; Peter Crauwels; Ger van Zandbergen
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

10.  Methodological approach to the ex vivo expansion and detection of T. cruzi-specific T cells from chronic Chagas disease patients.

Authors:  Gonzalo R Acevedo; Silvia A Longhi; Alcinette Bunying; Nazila Sabri; Augusto Atienza; María P Zago; Radleigh Santos; Valeria A Judkowski; Clemencia Pinilla; Karina A Gómez
Journal:  PLoS One       Date:  2017-05-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.